Table 1 Baseline characteristics of the study population.
Total (n = 489) | CKD+AMI group (n = 302) | CKD group (n = 187) | P | |
|---|---|---|---|---|
Age(y) | 70.68 ± 13.43 | 72.70 ± 9.85 | 69.74 ± 10.56 | 0.006 |
Male(n/%) | 280 (57.26) | 183 (60.65) | 97 (51.92) | NS |
BMI(kg/m2) | 21.67 ± 2.96 | 22.44 ± 2.99 | 20.2 ± 2.93 | NS |
Smoking(n/%) | 184 (37.63) | 126 (41.72) | 58 (31.02) | 0.021 |
DM(n/%) | 192 (39.26) | 124 (41.06) | 68 (36.36) | NS |
Hypertension(n/%) | 384 (78.53) | 241 (79.80) | 143 (76.47) | NS |
Dialysis(n/%) | 96 (19.63) | 24 (7.95) | 72 (38.50) | <0.001 |
Hospital stay(d) | 11.00 (6.00–18.00) | 10.00 (5.00–16.00) | 12.00 (9.00–23.00) | NS |
Hb(g/l) | 105.50 ± 27.86 | 113.96 ± 25.58 | 91.72 ± 25.81 | <0.001 |
WBC(x109/l) | 8.71 (5.97–13.01) | 8.80 (5.26–13.68) | 8.36 (5.20–13.26) | NS |
PLT(x109/l) | 164.11 ± 75.70 | 165.36 ± 73.73 | 163.00 ± 77.50 | NS |
Hs-cTnT(ng/l) | 162.50 (47.90–1155.00) | 668.20 (129.40–2716.25) | 52.60 (28.45–97.75) | <0.001 |
BNP(pg/ml) | 7081.00 (2596.00–23435.00) | 7450.00 (2827.00–24428.00) | 6546 (2253.75–21166.00) | NS |
BUN(mmol/l) | 14.06 (10.32–19.20) | 13.42 (9.32–18.21) | 14.84 (12.39–22.20) | NS |
Cystatin-C(mg/l) | 2.65 (1.97–3.81) | 2.48 (1.83–3.08) | 3.48 (2.35–5.21) | NS |
Cr(mg/dl) | 2.50 (1.85–3.99) | 2.30 (1.70–3.15) | 3.36 (2.08–6.21) | NS |
eGFR(ml/min/1.73 m2) | 23.88 ± 14.21 | 27.31 ± 14.38 | 18.13 ± 11.92 | <0.001 |
30–59 | 37.88 ± 6.18 | 38.51 ± 6.47 | 36.29 ± 5.09 | NS |
15–29 | 22.21 ± 4.21 | 22.58 ± 4.12 | 21.32 ± 4.33 | NS |
<15 | 9.07 ± 3.41 | 10.87 ± 2.69 | 7.86 ± 3.32 | <0.001 |
Urine protein(g/l) | 0.50 (0.10–1.00) | 0.30 (0.00–1.00) | 0.70 (0.20–2.50) | NS |
Urine WBC(/HP) | 2.00 (1.00–5.00) | 2.00 (1.00–5.00) | 2.00 (1.00–7.00) | NS |
Urine RBC(/HP) | 2.00 (1.00–6.00) | 2.00 (1.00–5.00) | 2.00 (1.00–9.00) | NS |
